A Fresh Take on Expanding Access in Oncology: A Road Map for Providers

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Faculty

Hansa Bhargava, MD

Chief Medical Officer, Medscape Education

Disclosures

Disclosure: Hansa Bhargava, MD, has the following relevant financial relationships:
Speaker or a member of a speakers bureau for: Chicco Baby Bottles

Mona Fouad, MD, MPH

Senior Associate Dean for Diversity and Inclusion
UAB School of Medicine
Professor and Director, Division of Preventive Medicine
Founding Director, Minority Health & Health Disparities Research Center
University of Alabama at Birmingham
Birmingham, Alabama

Disclosures

Disclosure: Mona Fouad, MD, MPH, has no relevant financial relationships.

Editor

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Shanthi Voorn, PhD, has disclosed no relevant financial relationships.

Content Reviewer

Amanda Jett, PharmD, BCACP

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Amanda Jett, PharmD, BCACP, has disclosed no relevant financial relationships.

processing....

Posted: 12/20/2021

This activity is intended for hematologists and oncologists, nurses, and cardiologists.

The goal of the activity is to improve the knowledge and confidence of providers in recognizing the breadth of diverse, disparate considerations impacting all patients that prevent them from accessing clinical trials.

Upon completion of this activity, participants should be able to:

Have increased knowledge regarding the
- Barriers for patients to access investigational treatments in clinical trials
Demonstrate greater confidence in their ability to
- Incorporate interprofessional strategies for expanded access to clinical trials
- Apply strategies to expand accessibility of information for all patients

Pre-Assessment Survey

Before you begin, please take this brief survey.

Page 1 of 7

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Hansa Bhargava, MD

Mona Fouad, MD, MPH

Editor

Shanthi Voorn, PhD

Content Reviewer

Amanda Jett, PharmD, BCACP

A Fresh Take on Expanding Access in Oncology: A Road Map for Providers

Pre-Assessment Survey